Trials / Completed
CompletedNCT00288405
The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System
Cordis Neurovascular Feasibility Study of the Enterprise Self-Expanding Stent System to Facilitate Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Codman & Shurtleff · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. Cordis Self Expanding Stent for use with embolic coils for the treatment of wide-neck, intracranial, saccular aneurysms arising from a parent vessel
Detailed description
This is a multi-center, prospective, non-randomized feasibility study including 30 subjects. Subjects will receive a safety follow-up evaluation at 30 days (+ two weeks) and an efficacy follow-up evaluation at 6 months (+ four weeks).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cordis Self Expanding Stent |
Timeline
- Start date
- 2004-06-01
- Completion
- 2005-12-01
- First posted
- 2006-02-08
- Last updated
- 2012-05-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00288405. Inclusion in this directory is not an endorsement.